Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil

PURPOSE: Globally, it is estimated that 71 million people are chronically infected with hepatitis C, and 10–20% of these will develop cirrhosis and hepatocellular carcinoma. The development of new direct-acting antiviral (DAA) drugs has contributed to sustained virological response (SVR), eliminatin...

Descripción completa

Detalles Bibliográficos
Autores principales: de Torres Santos, Ana Paula, Martins Silva, Vanessa Cristina, Mendes-Corrêa, Maria Cássia, Lemos, Marcilio Figueiredo, de Mello Malta, Fernanda, Santana, Rúbia Anita Ferraz, Dastoli, Gregório Tadeu Fernando, de Castro, Vanessa Fusco Duarte, Pinho, João Renato Rebello, Moreira, Regina Célia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917774/
https://www.ncbi.nlm.nih.gov/pubmed/33658809
http://dx.doi.org/10.2147/IDR.S247071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917774/
https://www.ncbi.nlm.nih.gov/pubmed/33658809
http://dx.doi.org/10.2147/IDR.S247071

Ejemplares similares